Healthcare CRO Services Market by Type (Early Phase Development, Clinical Development Services, Laboratory Services, and Consulting Services), Therapeutic Area (Oncology, CNS Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Diabetes, and Others), and End-User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2019–2026

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Research methodology

1.3.1. Secondary research

1.3.2. Primary research

1.3.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Porter's five forces analysis

3.1. Key Findings

3.1.1. Top Investment Pockets

3.2. Top player positioning

3.3. Market dynamics

3.3.1. Drivers

3.3.1.1. Rise in R&D investment

3.3.1.2. Significant increase in cancer incidence across the globe

3.3.2. Restraints

3.3.2.1. Dearth of skilled labors/healthcare professionals

3.3.3. Opportunities

3.3.3.1. Various growth opportunities in emerging economies

CHAPTER 4: HEALTHCARE CRO SERVICES MARKET, BY SERVICE TYPE

4.1. Overview

4.1.1. Market size and forecast, by service type

4.2. Early phase development

4.2.1. Key market trends and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market analysis, by country

4.3. Clinical development services

4.3.1. Key market trends and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market analysis, by country

4.4. Laboratory Services

4.4.1. Key market trends and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market analysis, by country

4.5. Consulting Services

4.5.1. Key market trends and opportunities

4.5.2. Market size and forecast, by region

4.5.3. Market analysis, by country

CHAPTER 5: CRO SERVICES MARKET, BY THERAPEUTIC AREA

5.1. Overview

5.1.1. Market size and forecast, by therapeutic area

5.2. Oncology

5.2.1. Market size and forecast, by region

5.2.2. Market analysis, by country

5.3. CNS Disorder

5.3.1. Market size and forecast, by region

5.3.2. Market analysis, by country

5.4. Cardiovascular disease

5.4.1. Market size and forecast, by region

5.4.2. Market analysis, by country

5.5. Metabolic disease

5.5.1. Market size and forecast, by region

5.5.2. Market analysis, by country

5.6. Infectious disease

5.6.1. Market size and forecast, by region

5.6.2. Market analysis, by country

5.7. Diabetes

5.7.1. Market size and forecast, by region

5.7.2. Market analysis, by country

5.8. Others

5.8.1. Market size and forecast, by region

5.8.2. Market analysis, by country

CHAPTER 6: CRO SERVICES MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast, by end user

6.2. Pharmaceutical & biopharmaceutical companies

6.2.1. Market size and forecast, by region

6.2.2. Market analysis, by country

6.3. Medical device companies

6.3.1. Market size and forecast, by region

6.3.2. Market analysis, by country

6.4. Academic institutes

6.4.1. Market size and forecast, by region

6.4.2. Market analysis, by country

CHAPTER 7: CRO SERVICES MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities

7.2.2. Market size and forecast, by country

7.2.3. Market size and forecast, by service type

7.2.4. Market size and forecast, by therapeutic area

7.2.5. Market size and forecast, by end user

7.2.5.1. U.S. market size and forecast, by service type

7.2.5.2. U.S. market size and forecast, by therapeutic area

7.2.5.3. U.S. market size and forecast, by end user

7.2.5.4. Canada market size and forecast, by service type

7.2.5.5. Canada market size and forecast, by therapeutic area

7.2.5.6. Canada market size and forecast, by end user

7.2.5.7. Mexico market size and forecast, by service type

7.2.5.8. Mexico market size and forecast, by therapeutic area

7.2.5.9. Mexico CRO services MARKET, by end user

7.3. Europe

7.3.1. Key market trends

7.3.2. Market size and forecast, by country

7.3.3. Market size and forecast, by service type

7.3.4. Market size and forecast, by therapeutic area

7.3.5. Market size and forecast, by end user

7.3.5.1. France market size and forecast, by service type

7.3.5.2. France market size and forecast, by therapeutic area

7.3.5.3. France market size and forecast, by end user

7.3.5.4. UK market size and forecast, by service type

7.3.5.5. UK market size and forecast, by therapeutic area

7.3.5.6. UK market size and forecast, by end user

7.3.5.7. Germany market size and forecast, by service type

7.3.5.8. Germany market size and forecast, by therapeutic area

7.3.5.9. Germany market size and forecast, by end user

7.3.5.10. Spain market size and forecast, by service type

7.3.5.11. Spain market size and forecast, by therapeutic area

7.3.5.12. Spain market size and forecast, by end user

7.3.5.13. Rest of Europe market size and forecast, by service type

7.3.5.14. Rest of Europe market size and forecast, by therapeutic area

7.3.5.15. Rest of Europe market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends and opportunities

7.4.2. Market size and forecast, by country

7.4.3. Market size and forecast, by therapeutic area

7.4.4. Market size and forecast, by end user

7.4.4.1. Japan market size and forecast, by service type

7.4.4.2. Japan market size and forecast, by therapeutic area

7.4.4.3. Japan market size and forecast, by end user

7.4.4.4. China market size and forecast, by service type

7.4.4.5. China market size and forecast, by therapeutic area

7.4.4.6. China market size and forecast, by end user

7.4.4.7. India market size and forecast, by service type

7.4.4.8. India market size and forecast, by therapeutic area

7.4.4.9. India market size and forecast, by end user

7.4.4.10. Australia market size and forecast, by service type

7.4.4.11. Australia market size and forecast, by therapeutic area

7.4.4.12. Australia market size and forecast, by end user

7.4.4.13. Rest of Asia-Pacific market size and forecast, by service type

7.4.4.14. Rest of Asia-Pacific market size and forecast, by therapeutic area

7.4.4.15. Rest of Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends and opportunities

7.5.2. Market size and forecast, by country

7.5.3. Market size and forecast, by service type

7.5.4. Market size and forecast, by therapeutic area

7.5.5. Market size and forecast, by end user

7.5.5.1. Brazil market size and forecast, by service type

7.5.5.2. Brazil market size and forecast, by therapeutic area

7.5.5.3. Brazil market size and forecast, by end user

7.5.5.4. South Africa market size and forecast, by service type

7.5.5.5. South Africa market size and forecast, by therapeutic area

7.5.5.6. South Africa market size and forecast, by end user

7.5.5.7. Saudi Arabia market size and forecast, by service type

7.5.5.8. Saudi Arabia market size and forecast, by therapeutic area

7.5.5.9. Saudi Arabia market size and forecast, by end user

7.5.5.10. Rest of LAMEA market size and forecast, by service type

7.5.5.11. Rest of LAMEA market size and forecast, by therapeutic area

7.5.5.12. Rest of LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. BioTelemetry Inc.

8.1.1. Company overview

8.1.2. Company snapshot

8.1.3. Operating business segments

8.1.4. Product portfolio

8.1.5. Business performance

8.2. CHARLES RIVER LABORATORIES Inc.

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Operating business segments

8.2.4. Product portfolio

8.2.5. Business performance

8.3. ICON.

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Operating business segments

8.3.4. Product portfolio

8.3.5. Business performance

8.4. IQVIA

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Operating business segments

8.4.4. Product portfolio

8.4.5. Business performance

8.5. Evotec SE

8.5.1. Company overview

8.5.2. Operating business segments

8.5.3. Product portfolio

8.5.4. Business performance

8.6. Laboratory Corporation of America Holdings

8.6.1. Company overview

8.6.2. Operating business segments

8.6.3. Product portfolio

8.6.4. Business performance

8.7. Medpace, Inc.

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Product portfolio

8.7.5. Business performance

8.8. PRA Health Science

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Operating business segments

8.8.4. Product portfolio

8.8.5. Business performance

8.9. Syngene International Limited

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Product portfolio

8.9.5. Business performance

8.10. Syneos Health

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Operating business segments

8.10.4. Product portfolio

8.10.5. Business performance

TABLE 01. GLOBAL CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 02. HEALTHCARE CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT, BY REGION, 2018–2026 ($MILLION)

TABLE 03. HEALTHCARE CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 04. CLINICAL DEVELOPMENT SERVICES MARKET BY REGION 2018–2026 ($MILLION)

TABLE 05. CLINICAL DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 06. HEALTHCARE CRO SERVICES MARKET FOR LABORATORY SERVICES MARKET BY REGION 2018–2026 ($MILLION)

TABLE 07. HEALTHCARE CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 08. HEALTHCARE CRO SERVICES MARKET FOR CONSULTING SERVICES BY REGION 2018–2026 ($MILLION)

TABLE 09. HEALTHCARE CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 10. GLOBAL CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 11. ONCOLOGY HEALTHCARE CRO SERVICES, BY REGION, 2018–2026 ($MILLION)

TABLE 12. CRO SERVICES MARKET FOR CNS DISORDER, BY REGION, 2018–2026 ($MILLION)

TABLE 13. CRO SERVICES MARKET FOR CARDIOVASCULAR DISEASE, BY REGION, 2018–2026 ($MILLION)

TABLE 14. CRO SERVICES MARKET FOR METABOLIC DISEASE, BY REGION, 2018–2026 ($MILLION)

TABLE 15. CRO SERVICES MARKET FOR INFECTIOUS DISEASE, BY REGION, 2018–2026 ($MILLION)

TABLE 16. HEALTHCARE CRO SERVICES MARKET FOR DIABETES, BY REGION, 2018–2026 ($MILLION)

TABLE 17. CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREA, BY REGION, 2018–2026 ($MILLION)

TABLE 18. GLOBAL CRO SERVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 19. CRO SERVICES MARKET, FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018–2026 ($MILLION)

TABLE 20. CRO SERVICES MARKET, FOR MEDICAL DEVICE, BY REGION, 2018–2026 ($MILLION)

TABLE 21. CARDIOVASCULAR DISEASE CRO SERVICES MARKET, FOR ACADEMIC INSTITUTES, BY REGION, 2018–2026 ($MILLION)

TABLE 22. CRO SERVICES MARKET, BY REGION, 2018–2026 ($MILLION)

TABLE 23. NORTH AMERICA CRO SERVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 24. NORTH AMERICA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 25. NORTH AMERICA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 26. NORTH AMERICA CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 27. U.S. CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 28. U.S. CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 29. U.S. CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 30. CANADA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 31. CANADA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 32. CANADA CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 33. MEXICO CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 34. MEXICO CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 35. MEXICO CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 36. EUROPE CRO SERVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 37. EUROPE CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 38. EUROPE CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 39. EUROPE CRO SERVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 40. FRANCE CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 41. FRANCE CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 42. FRANCE CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 43. UK CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 44. UK CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 45. U.K CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 46. GERMANY CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 47. GERMANY CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 48. GERMANY CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 49. SPAIN CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 50. SPAIN CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 51. SPAIN CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 52. REST OF EUROPE CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 53. REST OF EUROPE CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 54. REST OF EUROPE CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 55. ASIA-PACIFIC CRO SERVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 56. ASIA-PACIFIC CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 57. ASIA-PACIFIC CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 58. ASIA-PACIFIC CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 59. JAPAN CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 60. JAPAN CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 61. JAPAN CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 62. CHINA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 63. CHINA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 64. CHINA CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 65. INDIA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 66. INDIA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 67. INDIA CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 68. AUSTRALIA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 69. AUSTRALIA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 70. AUSTRALIA CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 71. REST OF ASIA-PACIFIC CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 72. REST OF ASIA-PACIFIC CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 73. REST OF ASIA-PACIFIC CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 74. LAMEA CRO SERVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)

TABLE 75. LAMEA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 76. LAMEA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 77. LAMEA CRO SERVICES MARKET, BY END USER, 2018–2026 ($MILLION)

TABLE 78. BRAZIL CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 79. BRAZIL CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 80. BRAZIL CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 81. SOUTH AFRICA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 82. SOUTH AFRICA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 83. SOUTH AFRICA CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 84. SAUDI ARABIA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 85. SAUDI ARABIA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 86. SAUDI ARABIA CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 87. REST OF LAMEA CRO SERVICES MARKET, BY SERVICE TYPE, 2018–2026 ($MILLION)

TABLE 88. REST OF LAMEA CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018–2026 ($MILLION)

TABLE 89. REST OF LAMEA CRO SERVICES MARKET, BY END USER, 2018–2026

TABLE 90. BIOTELEMETRY: COMPANY SNAPSHOT

TABLE 91. BIOTELEMETRY: OPERATING BUSINESS SEGMENTS

TABLE 92. BIOTELEMETRY: PRODUCT PORTFOLIO

TABLE 93. CHARLES RIVER: COMPANY SNAPSHOT

TABLE 94. CHARLES RIVER: OPERATING BUSINESS SEGMENTS

TABLE 95. CHARLES RIVER: PRODUCT PORTFOLIO

TABLE 96. ICON: COMPANY SNAPSHOT

TABLE 97. ICON: PRODUCT PORTFOLIO

TABLE 98. IQVIA: COMPANY SNAPSHOT

TABLE 99. IQVIA: OPERATING BUSINESS SEGMENTS

TABLE 100. IQVIA: PRODUCT PORTFOLIO

TABLE 101. EVOTEC.: COMPANY SNAPSHOT

TABLE 102. EVOTEC.: OPERATING BUSINESS SEGMENTS

TABLE 103. EVOTEC.: PRODUCT PORTFOLIO

TABLE 104. LABCORP: COMPANY SNAPSHOT

TABLE 105. LABCORP: OPERATING SEGMENTS

TABLE 106. LABCORP: PRODUCT PORTFOLIO

TABLE 107. MEDPACE: COMPANY SNAPSHOT

TABLE 108. MEDPACE: OPERATING BUSINESS SEGMENTS

TABLE 109. MEDPACE: PRODUCT PORTFOLIO

TABLE 110. PRA: COMPANY SNAPSHOT

TABLE 111. PRA: OPERATING SEGMENTS

TABLE 112. PRA: PRODUCT PORTFOLIO

TABLE 113. SYNGENE: COMPANY SNAPSHOT

TABLE 114. SYNGENE: OPERATING BUSINESS SEGMENTS

TABLE 115. SYNGENE: PRODUCT PORTFOLIO

TABLE 116. SYNEOS: COMPANY SNAPSHOT

TABLE 117. SYNEOS: OPERATING SEGMENTS

TABLE 118. SYNEOS: PRODUCT PORTFOLIO